newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

DUBLIN and CHICAGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat